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OBJECTIVES We propose a new strategy using coarctation repair together with a polidioxanone absorbable
pulmonary artery banding to limit operative risk and to spare infants with aortic coarctation
subsequent operations.
BACKGROUND The alternative for the surgical management of aortic coarctation associated with ventricular
septal defect (VSD) is single-stage repair versus coarctation repair with or without banding
of the pulmonary artery.
METHODS Eleven infants (mean weight 2,560 6 1,750 g, range 1,320 to 3,800 g) underwent a
coarctation repair with a polydioxanone banding. Seven had a trabecular and four a
perimembranous VSD. The mean size of the VSD was 5 6 0.7mm (range 4 to 7 mm). The
systolic pulmonary pressure was .80% of the aortic pressure in all. The pulmonary band was
tightened until the systolic pulmonary pressure fell below 50% of the aortic pressure.
RESULTS There were no hospital deaths. The reabsorption of the banding was complete after 5.7
months in all patients (3 to 6.5 months). The VSD closed completely in four infants and
partially in six, in whom the pulmonary artery pressure was normal without evidence for
significant left-to-right shunt. One patient with a large trabecular VSD underwent surgical
closure of his defect after four months. Finally, a subsequent open-heart surgery could be
avoided in 91% (10/11) of patients.
CONCLUSIONS Provided the VSD belongs to types prone to close spontaneously, this policy may reduce the
number of surgical procedures per infant as well as in-hospital mortality and morbidity rates.
It should be proposed as an alternative to more complex procedures. (J Am Coll Cardiol
1999;34:866–70) © 1999 by the American College of Cardiology
Decision making for the surgical management of aortic
coarctation associated with ventricular septal defect (VSD)
is sometimes difficult in newborn infants (1–3). The coarc-
tation of the aorta and the VSD may be repaired during a
single-stage procedure or by initial coarctation repair with
or without pulmonary artery banding. Single-stage repair is
now largely applied to coarctation associated with complex
intracardiac anatomy or for interrupted aortic arch with
VSD (4,5). Hitherto, however, the indications for single
stage repair in coarctation with isolated VSD are not clearly
defined. Recent reports suggested that a successful manage-
ment of the majority of the neonates with coarctation and
associated VSD was possible with repair of coarctation alone
(1,2). Nevertheless, it appears that more than half of the
patients who underwent a coarctation repair alone had to
undergo subsequent VSD closure or secondary pulmonary
artery banding without delay because these patients could
not be weaned from the ventilator. Conversely, the operative
risk of single-stage repair might be high in low-weight
infants, and pulmonary artery banding has the disadvantage
of requiring a subsequent operation for debanding. Today,
predictors of closure of the VSDs associated with coarcta-
tion of the aorta are scarce and contradictory (6,7). How-
ever, trabecular or muscular and perimembranous defects
are prone to close spontaneously, in contrast to malalign-
ment and infundibular VSDs (8,9).
In this study, we report on a series of selected neonates
with coarctation of the aorta and either trabecular or
perimembranous VSD, in whom we repaired the coarcta-
tion and put an absorbable polydioxanone pulmonary band.
The objective of this study was to find a compromise
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between the standard attitudes mentioned above that could
be adapted for the treatment of ambiguous cases.
METHODS
Population. Over a period of three years, we selected 11
neonates (mean weight 2,560 6 1,750 g, range 1,320 to
3,800 g) with coarctation of the aorta and VSD for a
coarctation repair associated with an absorbable pulmonary
artery banding. The selection criteria were the following: 1)
coarctation of the aorta with or without aortic arch hy-
poplasia; 2) VSD, either trabecular or perimembranous; 3)
maximum defect size ,8 mm; and 4) nonrestrictive defects
with systolic pulmonary pressure .80% of systolic aortic
pressure measured at the right arm. Seven patients had a
trabecular defect (five mid-trabecular, multiple in one and
apical in one) and four patients had a perimembranous
defect. The mean size of the VSD was 5 6 0.7 mm or 2.6 6
0.6 cm/m2 (range 4 to 7mm; 1.7 to 3.2 cm/m2). Six patients
received prostaglandin E1 (PGE1) infusion to relieve the
coarctation; the ductus arteriosus was closed in the other five
patients. Five patients were ventilated and had to receive
inotropic support for left ventricular systolic dysfunction at
admission. Patients with complex intracardiac anatomy and
interrupted aortic arch were excluded. Patients with very
large (.8 mm), infundibular VSDs and leftward malaligned
outlet septum were excluded as well. Anatomic characteris-
tics of the aortic arch and of the VSD were obtained by
echocardiography. The patient data are summarized in
Table 1.
Operative technique. Mean age at operation was 10.5 6
3.5 days (range 8 to 41 days). All patients underwent an
aortic arch reconstruction by extended end-to-end anasto-
mosis through a left posterolateral thoracotomy except in
one very low weight infant (1,435 g), in whom a midline
sternotomy was used. A 5-mm pulmonary artery band made
of interlaced fibers of polydioxanone (PDS) was tightened
around the pulmonary artery trunk until the distal systolic
pulmonary pressure fell below 50% of the aortic systolic
pressure.
Follow-up. All patients were followed up for a mean of
16 6 11 months (range 5 to 27 months). Clinical exami-
nation, chest roentgenogram and echocardiography were
performed monthly during the first six months after oper-
ation. The procedure was considered to be successful when
the VSD was closed or hemodynamically nonsignificant
after the pulmonary banding was completely absorbed.
Abbreviations and Acronyms
PGE1 5 prostaglandin E1
VSD 5 ventricular septal defect
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RESULTS
Mortality and morbidity. There were no hospital deaths
and no late deaths. Intensive care unit stay was 3 6 2 days.
One very low weight infant (1,320 g) had to be reintubated
for a chylothorax, requiring drainage for three days. One
patient had a transient right ventricular failure while the
pulmonary band was adequately sized. One patient (1435 g)
had a recoarctation two months after surgery and underwent
a successful balloon angioplasty.
Pulmonary artery banding. Three patients needed medi-
cation at hospital discharge (angiotensin-converting enzyme
inhibitors and diuretics) because of failure to thrive. These
three patients had persistent indirect echocardiographic
measurements for a significant left-to-right shunt, while
their banding was considered to be adequately sized (right
ventricle-pulmonary Doppler-flow velocity .4 m/s). All
three could be weaned of all medications after 4, 6 and 8
weeks, respectively. The remaining eight patients were
discharged without medication.
The reabsorption of the banding was complete in all
patients after a mean follow-up of 5.75 6 1 month (range 3
to 6.5 months). At this time, no remaining trace of the
banding could be found on echocardiography, and the
maximum Doppler-flow velocity through the pulmonary
artery was ,1.5 m/s in all patients. No distortion of the
pulmonary arteries could be observed in any patient.
VSD closure. One patient with a 7-mm trabecular VSD
underwent surgical closure of the defect at four months of
age. Indeed, after reabsorption of the pulmonary banding,
he had a persistent significant left-to-right shunt and
pulmonary hypertension. During surgery, no trace of the
pulmonary banding could be found around the pulmonary
artery.
The VSD closed completely in four patients within the
delay of reabsorption of the banding. In the remaining six
patients, the VSD closed partially but the pulmonary
pressure was normal and there was no evidence for a
significant left-to-right shunt. None of these patients re-
ceived medication after reabsorption of the pulmonary
banding. Finally, 10 of 11 patients (91%; CL 95% 73.7% to
100%) did not undergo a second surgical procedure.
DISCUSSION
Strategies for the treatment of coarctation with VSD. A
well-defined algorithm for the treatment of the infant with
coarctation of the aorta and VSD has not been clearly
proposed. Issues such as the choice of intervention remain
unresolved at the present time (1–5). Indeed, an alternative
is coarctation repair with or without pulmonary banding or
single-stage repair under cardiopulmonary bypass. These
three strategies have their respective advantages and limits.
Individually adapted treatment has to take into account the
operative risk, the need for subsequent intervention as well
as the hemodynamic, anatomic and putative evolution of the
VSD.
Single-stage repair is now the treatment of choice for
complex congenital heart diseases with coarctation of the
aorta and VSD amenable to biventricular repair (4,5). In
coarctation with VSD, the single-stage repair gives excellent
results with a low mortality rate. Still, the operative risk
might be much higher in low-weight or in premature
infants, particularly regarding neurologic consequences of
the circulatory arrest.
According to recent surgical series, it appears that most
infants with coarctation of the aorta and VSD can be treated
by coarctation repair alone (1-4). In these series, 40% to
45% of the patients treated with this technique did not
require secondary pulmonary banding or open-heart closure
of the VSD. This means that 55% to 60% of the patients in
these series required a secondary operation, either VSD
closure or pulmonary artery banding. It is of note that most
of these subsequent procedures had to be performed within
a few days after coarctation repair as a result of persistent
pulmonary overflow. In addition, these secondary proce-
dures are performed in infants in worse condition than is
deemed ideal. Consequently, the mortality in this category
of patients is not significantly different than the mortality of
single stage repair.
In patients treated with pulmonary artery banding, the
obvious inconvenience is the need for debanding with or
without VSD closure. In addition, pulmonary artery scar-
ring is a frequent complication requiring pulmonary artery
angioplasty if the band is left for more than six months (10).
As the resorption of the polydioxanone band occurred
within the first six months in our series, we did not observe
any scar on the pulmonary artery after resorption. It is of
note that the surgeon who reoperated on the patient who
still had a large VSD after the resorption of the banding did
not find any sequelae on the pulmonary trunk.
Selection of patients for an absorbable pulmonary band-
ing. Various criteria have been proposed to predict the need
for surgical closure of VSDs associated with coarctation of
the aorta. The size of the VSD is not a good predictor of
spontaneous closure, as even large VSDs (.1 cm/m2) may
close rapidly (11–13). The importance of the left-to-right
shunt has also been proposed, but none of the patients with
coarctation of the aorta and VSD is currently catheterized in
our institution. Therefore, the quantification of left-to-right
shunt relies on indirect clinical, radiologic and echocardio-
graphic arguments. However, the left ventricle is often small
relative to the right ventricle in coarctation of the aorta with
VSD, and the lack of volume loading of these “small”
ventricles does not allow a good estimation of the shunt
through the VSD. Finally, the anatomic features of the
VSD seems to be the best argument to predict spontaneous
closure (11). Perimembranous and trabecular defects repre-
sent two-thirds of the VSDs associated with coarctation of
the aorta (6). These defects are characterized by a high
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incidence of spontaneous closure in contrast to malalign-
ment VSDs.
For these reasons, we hypothesized that a transient
pulmonary artery banding could be useful in infants with
coarctation associated with VSDs prone to spontaneous
closure. Our aim was to simplify the surgical procedure and
to spare these children the need for a second operation. At
our institution, initial combined repair of both aortic coarc-
tation and the VSD would be undertaken rather than
pulmonary artery banding or coarctation repair alone in
nonrestrictive VSDs. During the period of inclusion of this
series, all patients with left inward malalignment of the
outlet septum underwent a single-stage repair as well as the
patients with very large VSD (.8 mm). We excluded from
the study the patients with a malalignment defect with left
outflow tract obstruction, as biventricular outflow tract
obstruction in these cases has been proved to result in
increased mortality (14). The infants with restrictive VSDs
underwent coarctation repair alone. Indications for “defin-
itive” pulmonary artery banding were mainly “huge” VSDs
(.50% of the septum) and complex intracardiac anatomy.
In the patients of this series, the VSD was not restrictive,
and the alternative was complete repair versus coarctation
repair with an absorbable pulmonary artery banding. Still, it
remains difficult to predict the hemodynamic consequences
of a mid-sized VSD in patients with associated coarctation
of the aorta who receive PGE1 to maintain the arterial duct
patent. In neonates presenting early in life, the pulmonary
pressure is often systemic in such a situation and Doppler
assessment across the VSD can yield a high right ventricular
and pulmonary pressure in the face of a restrictive VSD.
This could have happened in some of our patients. How-
ever, these echographic hemodynamic findings are still
ambiguous in these patients when dealing with the best
surgical technique to be applied. Our results are encourag-
ing, as there was no mortality and only one patient had to be
reoperated on for closure of the VSD at four months of age.
In addition, intensive care unit stay was short and only three
patients received medication for persistent pulmonary over-
flow at discharge. There was no late complication of the
pulmonary banding, and the VSD closed or became hemo-
dynamically insignificant during the delay of reabsorption of
the banding. Nevertheless, the only way to determine
whether or not this alternative for the treatment of VSD
with associated coarctation has a significant impact on the
decision process regarding VSD closure in this setting
would be to perform a control study with regards to VSD
size with and without pulmonary banding.
Pulmonary artery banding: technique and perspectives.
The surgical calibration of the banding was performed by
measuring the pulmonary pressure. In our smallest patient,
the banding was placed more loosely than ideal, and the
pulmonary pressure was estimated to be 60% of the aortic
pressure at postoperative control. It is also of note that the
three patients who needed diuretics and angiotensin-
converting enzyme inhibitors at discharge apparently had a
sufficient obstruction of the pulmonary artery. The tech-
nique of banding with a 5-mm-large polydioxanone band
may lead to underestimating the pulmonary artery pressure,
as simplified Bernouilli equation might overestimate the
Doppler gradient through this wide banding (Fig. 1).
Notwithstanding this limitation, the pulmonary artery con-
striction increased in all patients with growth and led to a
reduction in the left-to-right shunt. Indeed, no patient
received any medication after two months. The reabsorption
of the banding was progressive in all patients and the right
ventricular pressure never exceeded the left ventricular
pressure in the four patients in whom the VSD closed
before the reabsorption was completed.
Extrathoracically adjustable pulmonary bands have been
used in various indications such as training of the subpul-
monary left ventricle in transposition of the great arteries or
in double-discordance before a switch or a “double-switch”
operation, respectively (15). Percutaneously adjustable pul-
monary artery band has also been proposed in situations in
which the precise adjustment for sufficient reduction of the
pulmonary blood flow can cause life-threatening hemody-
namic changes (16–18). Absorbable polidioxanone pulmo-
nary band as a palliative procedure has been used success-
fully by Gutierrez de Loma et al. (19) in five patients with
atrioventricular canal or VSD in whom pulmonary recon-
struction was avoided at subsequent reoperation. Recently,
Peek et al. (20) reported two cases of VSD (one associated
with coarctation of the aorta) successfully treated with an
absorbable pulmonary artery banding made of braided
Dexon. In our series, reabsorption of the banding occurred
5.7 months after operation, and this delay might be too
short to observe a sufficient closure of some VSDs. Another
Figure 1. Echocardiography at day 5 after banding of the pulmo-
nary artery in a 1,320-g neonate. PA 5 pulmonary artery trunk;
PAB 5 5-mm polydioxanone absorbable banding; PV 5 pulmo-
nary valve.
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alternative to our technique could be using balloon-dilatable
or staged expanding pulmonary artery band (21,22).
Conclusions. Provided the VSD associated with coarcta-
tion of the aorta belongs to types characterized by a high
incidence of spontaneous closure, banding the pulmonary
artery with absorbable material may reduce the number of
surgical procedures per infant, in-hospital mortality and
morbidity rates. It should be proposed, in selected infants, as
an alternative in the panel of surgical options in the
treatment of coarctation of the aorta with isolated VSD.
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